Is there an effect of obstructive sleep apnea syndrome on oxidative stress and inflammatory parameters in patients with craniofacial anomalies?
The aim of this study was to test the hypothesis that obstructive sleep apnea syndrome (OSAS) exhibits oxidative stress and inflammation in patients who have a congenital, craniofacial anomaly.This prospective, cross-sectional cohort study included ambulant sleep study data to asses OSAS in patients with syndromic craniosynostosis and Treacher Collins syndrome. Laboratory analyses were performed including malondialdehyde, tumor necrosis factor α (TNF-α), interleukin 6, and high-sensitivity C-reactive protein.Forty-eight patients were included; 11 were adults; 37 were children. The patients' body mass indexes were normal, with a median (SD) of 0.7 (-1.82 to 2.48) in children and 20.5 (15.2-29.4) in adults. Obstructive sleep apnea syndrome was diagnosed in 23 of 48 patients. It was mild (median obstructive apnea-hypopnea index [oAHI], 2.3; oxygenation-desaturation index [ODI], 0.9) in 16 patients and moderate/severe in 7 patients (median oAHI, 10.8; ODI, 5.0). Neither oxidative stress nor inflammation had a correlation with the oAHI and ODI. Only TNF-α was found significantly higher in both the OSAS and non-OSAS groups compared with the reference values (median, 15.1 pg/mL and 12.3 pg/mL versus 4.05 [0.0-8.1 pg/mL], P < 0.001 and P < 0.001, respectively).Based on our findings we conclude that (mainly mild) OSAS, oxidative stress, as well as high-sensitivity C-reactive protein and interleukin 6 levels are not abnormal in the day time in a population of nonobese patients with a craniofacial anomaly. The increased level of TNF-α cannot be explained by OSAS. Future research should focus on mapping chronobiologic changes for further interpretation of the results.
From the Departments of *Plastic, Reconstructive and Hand Surgery, †Bioinformatics, ‡Intensive Care Medicine, and §Department of Biochemistry, Academic Medical Center, Amsterdam, and ∥Pediatrics, Dutch Craniofacial Centre, Erasmuc Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
Caroline
C
Driessen
Raul G
RG
Plomp
Peter J
PJ
van der Spek
Can
C
Ince
Wim
W
Kulik
Irene M J
IM
Mathijssen
Koen F M
KF
Joosten
D000293:Adolescent; D000328:Adult; D015992:Body Mass Index; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003398:Craniosynostoses / Q000503:physiopathology*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007223:Infant; D018836:Inflammation Mediators / Q000097:blood*; D008297:Male; D008342:Mandibulofacial Dysostosis / Q000503:physiopathology*; D008875:Middle Aged; D018384:Oxidative Stress / Q000502:physiology*; D017286:Polysomnography; D011446:Prospective Studies; D012016:Reference Values; D020181:Sleep Apnea, Obstructive / Q000503:physiopathology*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D055815:Young Adult
D018836:Inflammation Mediators; D014409:Tumor Necrosis Factor-alpha